E-Prescribing Systems Should Provide Individualized Cost Data, Pfizer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Specific patient information should be provided at the point of care, Pfizer tells the HHS subcommittee charged with setting e-prescribing standards. Express Scripts prefers providing formulary and copay data, rather than actual cost information.
You may also be interested in...
RxHub Names New CEO
RxHub Chief Operating Officer David McLean, PhD, is taking over as CEO of the pharmacy benefit management industry electronic prescribing company
RxHub Names New CEO
RxHub Chief Operating Officer David McLean, PhD, is taking over as CEO of the pharmacy benefit management industry electronic prescribing company
E-Prescription System Funding Transparency Recommended In Pfizer Study
Electronic prescribing systems should be designed to prevent the promotion of pharmaceuticals for non-clinical reasons, such as the benefit to third-party entities that may fund the system, a RAND expert panel suggests in a report commissioned by Pfizer.